Cargando…
Quantitative phenotypic and pathway profiling guides rational drug combination strategies
Advances in target-based drug discovery strategies have enabled drug discovery groups in academia and industry to become very effective at generating molecules that are potent and selective against single targets. However, it has become apparent from disappointing results in recent clinical trials t...
Autores principales: | Dawson, John C., Carragher, Neil O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035564/ https://www.ncbi.nlm.nih.gov/pubmed/24904421 http://dx.doi.org/10.3389/fphar.2014.00118 |
Ejemplares similares
-
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells
por: Athanasiadis, Paschalis, et al.
Publicado: (2023) -
Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
por: Ayoun Alsoud, Rami, et al.
Publicado: (2023) -
Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19
por: Blaess, Markus, et al.
Publicado: (2020) -
Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
por: Silva, Ana Catarina Cristovão, et al.
Publicado: (2019) -
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment
por: Dawson, John C., et al.
Publicado: (2021)